MARKET

AXGT

AXGT

Axovant Gene Therapies
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.490
-0.060
-2.35%
Closed 16:00 04/03 EDT
OPEN
2.550
PREV CLOSE
2.550
HIGH
2.670
LOW
2.400
VOLUME
40.76K
TURNOVER
--
52 WEEK HIGH
9.68
52 WEEK LOW
1.410
MARKET CAP
91.69M
P/E (TTM)
-0.8539
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 8 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average AXGT stock price target is 21.00 with a high estimate of 44.00 and a low estimate of 10.00.

EPS

AXGT News

More
  • Axovant to Participate in Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Day
  • GlobeNewswire · 5d ago
  • Selloff creating bargains in healthcare - Baird
  • Seeking Alpha - Article · 03/25 17:54
  • The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
  • Benzinga · 03/12 11:37
  • 90 Biggest Movers From Yesterday
  • Benzinga · 03/12 10:10

Industry

Biotechnology & Medical Research
-0.50%
Pharmaceuticals & Medical Research
-0.22%

Hot Stocks

Symbol
Price
%Change

About AXGT

Axovant Gene Therapies Ltd., formerly Axovant Sciences Ltd., is a clinical-stage biopharmaceutical company. The Company is focused on acquiring, developing and commercializing therapeutics for the treatment of dementia, including Alzheimer's disease and Lewy body dementia. The Company intends to develop a pipeline of product candidates to address the cognitive, functional and behavioral aspects of dementia and related neurological disorders. The Company also focuses on developing nelotanserin, a selective 5-hydroxytryptamine 2A receptor inverse agonist, for the treatment of rapid eye movement (REM) behavior disorder (RBD) in DLB patients, and visual hallucinations in patients with Lewy body dementia. Its AXO-Lenti-PD is an in vivo lentiviral gene therapy investigational product candidate and being developed for the one-time treatment of Parkinson’s disease.
More

Webull offers kinds of Axovant Gene Therapies Ltd stock information, including NASDAQ:AXGT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AXGT stock news, and many more online research tools to help you make informed decisions.